Wednesday, March 18, 2020 4:14:35 PM
Recent CODX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 09:05:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:01:26 PM
- Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results • PR Newswire (US) • 11/07/2024 09:01:00 PM
- Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in Düsseldorf, Germany on Nov 11-14, 2024 • PR Newswire (US) • 11/05/2024 02:30:00 PM
- Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast • PR Newswire (US) • 10/25/2024 08:01:00 PM
- Co-Diagnostics, Inc. to Host Booth at Medlab Africa in Cape Town on Oct 22-24, 2024 • PR Newswire (US) • 10/21/2024 01:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/18/2024 08:30:42 PM
- Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention & Expo on Oct 2-3 • PR Newswire (US) • 10/02/2024 01:30:00 PM
- Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan • PR Newswire (US) • 09/24/2024 01:30:00 PM
- Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test • PR Newswire (US) • 09/05/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2024 08:30:22 PM
- Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C. • PR Newswire (US) • 08/15/2024 01:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:06:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:01:23 PM
- Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results • PR Newswire (US) • 08/08/2024 08:01:00 PM
- Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago • PR Newswire (US) • 07/29/2024 01:30:00 PM
- Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast • PR Newswire (US) • 07/25/2024 01:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/16/2024 08:15:11 PM
- Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States • PR Newswire (US) • 07/02/2024 01:30:00 PM
- Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21 • PR Newswire (US) • 06/18/2024 05:30:00 PM
- Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform • PR Newswire (US) • 06/14/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 11:35:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/28/2024 08:01:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/28/2024 08:01:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:05:53 PM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM